Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction | Zendy

Dimitrios Alexopoulos | Zendy; Ioanna Xanthopoulou | Zendy; Vassilios Gkizas | Zendy; George Kassimis | Zendy; Konstantinos C. Theodoropoulos | Zendy; George Makris | Zendy; Nikolaos Koutsogiannis | Zendy; Αναστασία Δαμέλου | Zendy; Grigorios Tsigkas | Zendy; Periklis Davlouros | Zendy; George Hahalis | Zendy

Open Access

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction

Author(s) -

Dimitrios Alexopoulos,

Ioanna Xanthopoulou,

Vassilios Gkizas,

George Kassimis,

Konstantinos C. Theodoropoulos,

George Makris,

Nikolaos Koutsogiannis,

Αναστασία Δαμέλου,

Grigorios Tsigkas,

Periklis Davlouros,

George Hahalis

Publication year - 2012

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.112.972323

Subject(s) - ticagrelor , prasugrel , medicine , clopidogrel , percutaneous coronary intervention , myocardial infarction , p2y12 , cardiology , st segment , anesthesia

Ticagrelor and prasugrel provide stronger platelet inhibition compared with clopidogrel. Direct pharmacodynamic comparison between them has not yet been reported in ST-segment-elevation myocardial infarction patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research